Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | TNF | P01375 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29197402 | 0.87 | MAOA (0.39) | MAOACES1BCHEALDH1A1CYP2C19 | |
| SCHEMBL769934 | 0.74 | MAOA (0.71) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL10703055 | 0.73 | MAOA (0.59) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL23839 | 0.72 | MAOA (0.57) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL10756250 | 0.71 | MAOA (0.55) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL18143 | 0.71 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL1527782 | 0.71 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL2319027 | 0.71 | MAOA (0.90) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL29448801 | 0.71 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL29357010 | 0.71 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670864-B1 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | SABIC INNOVATIVE PLASTICS IP (NL) | 2012-02-29 | — | — | EP | claimed |
| EP-1670864-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-06-21 | — | — | EP | claimed |
| US-6995266-B2 | Thermally stable anthrapyridone compositions | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | claimed |
| WO-2005033210-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2005-04-07 | — | — | US | claimed |
| US-3972881-A | VAT, CELLULOSE | CIBA-GEIGY CORPORATION (US) | 1976-08-03 | — | — | US | claimed |
| JP-3163459-A | — | — | None | — | — | JP | disclosed |
| EP-1670864-B1 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | SABIC INNOVATIVE PLASTICS IP (NL) | 2012-02-29 | — | — | EP | disclosed |
| US-7655085-B2 | Such as 3'-phenyl-2-methyl-4(anthraquinoneamino)-1,9-anthrapyridone; useful as colorants in resin and are resistant to degradation and color shift when processed with resins at high temperatures | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-02-02 | — | — | US | disclosed |
| EP-1670864-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060106140-A1 | Thermally stable anthrapyridone | GENERAL ELECTRIC COMPANY (US) | 2006-05-18 | — | — | US | disclosed |
| US-6995266-B2 | Thermally stable anthrapyridone compositions | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | disclosed |
| WO-2005033210-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2005-04-07 | — | — | US | disclosed |
| JP-H03163459-A | ELECTROPHOTOGRAPHIC SENSITIVE BODY AND ORIGINAL PRINTING PLATE FOR ELECTROPHOTOGRAPHIC PROCESS | FUJI PHOTO FILM CO LTD | 1991-07-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | IK, H1-0, H1-4 | MAOA 2660/4885CES1 3740/4885BCHE 4558/4885 |
| US-20060106140-A1 | Thermally stable anthrapyridone | IK, H1-0, H1-4 | MAOA 2639/4885CES1 3731/4885BCHE 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.